ReSHAPE Workshop

5 Dec 2024 | Berlin

Thursday, 5 December 2024 | 13:30 - 13:50

ProTreg Trial – A phase I/IIa study to investigate the safety and tolerability of Tregs as an adjunctive therapy in CD kidney recipients following anti-thymocyte (ATG) induction therapy

Format:In-person
  • In vivo engraftment (part 1)